Musashino-shi, Tokyo, Japan Clinical Trials

A listing of Musashino-shi, Tokyo, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 407 clinical trials
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

hemodynamic evaluation
heart disease
ventricular septal defect
septal defect
hypertension
Kyorin University Hospital
 (2.8 away) Contact site
  • 37 views
  • 16 Jul, 2021
  • +265 other locations
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.

Center Hospital of the National Center for Global Health and Medicine
 (8.4 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +83 other locations
A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

This study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma.

cyclin d1
rituximab
bendamustine
acalabrutinib
Research Site
 (8.5 away) Contact site
  • 1270 views
  • 24 Jul, 2021
  • +250 other locations
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

This is a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 2 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

chemoradiotherapy
methylated
bevacizumab
astrocytoma
Tokyo Women's Medical University Hospital
 (8.7 away) Contact site
  • 1520 views
  • 25 Jul, 2021
  • +69 other locations
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant Ovarian Cancer.

National Defense Medical College Hospital
 (8.1 away) Contact site
  • 101 views
  • 01 Jul, 2021
  • +88 other locations
Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma

The purpose of this study is to evaluate safety and pharmacokinetics as well as the biodistribution of OTSA101-DTPA-111In and to evaluate the safety of intravenous administration of OTSA101-DTPA-90Y.

Cancer Institute Hospital of JFCR
 (5.5 away) Contact site
  • 4 views
  • 22 Apr, 2021
  • +2 other locations
Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects 1 Month to <17 Years Undergoing MRI Scans

This is a randomized, double-blind, dose-ranging study of the efficacy and safety of dexmedetomidine (DEX) when used with propofol as needed, for procedural sedation of pediatric subjects 1 month to <17 years of age undergoing MRI scans in the US and Japan.

Tokyo Metropolitan Children's Medical Center
 (6.2 away) Contact site
  • 5 views
  • 26 Jul, 2021
  • +37 other locations
A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

A clinical study to evaluate the residual effects of TS-142 on driving performance in healthy and elderly subjects.

Taisho Pharmaceutical Co., Ltd selected site
 (5.5 away) Contact site
  • 0 views
  • 03 Feb, 2021
  • 1 location
A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

A clinical study to evaluate the effects on QT/QTc Interval of TS-142 in Healthy Adult Subjects

Taisho Pharmaceutical Co., Ltd selected site
 (8.4 away) Contact site
  • 0 views
  • 22 Jun, 2021
  • 1 location
A Study of AZD8233 in Participants With Dyslipidemia.

A Phase 1 and 2 Study of AZD8233 in Participants with Dyslipidemia and this study consists of Part A and Part B. Part A is designed as a randomized, single-blind (blinding of participants and sites), placebo-controlled, multiple dose, phase 1 study. Part B is designed as a randomized, double-blind, placebo-controlled, …

Research Site
 (7.3 away) Contact site
  • 0 views
  • 07 May, 2021
  • +1 other locations